Actively Recruiting
The Impact of Chronic E-Cigarette Usage on Microvascular Health
Led by Virginia Commonwealth University · Updated on 2026-04-03
44
Participants Needed
1
Research Sites
145 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is focused on investigating the mechanisms involved in microvascular health in subjects that use e-cigarettes frequently. To explore microvascular health, different techniques and compounds. For one of the tests, iontophoresis, the drug's use will be stored and handled as described by the approved IND and non-IDS plan.
CONDITIONS
Official Title
The Impact of Chronic E-Cigarette Usage on Microvascular Health
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between 18 and 29 years of age
- For e-cigarette users: used e-cigarettes with nicotine at least 3 times per week for 6 months or more
- For non e-cigarette users: between 18 and 29 years of age
You will not qualify if you...
- Younger than 18 years or older than 29 years
- Former smoker or former combustible tobacco user
- Use of cigarettes for 15 days or more in the past 60 days
- Use of other tobacco products, marijuana, illicit or prescription drugs weekly or more in the past 60 days
- Evidence of cardiovascular, pulmonary, renal, hepatic, metabolic, cerebral diseases or sleep disorders
- Use of medication that affects cardiopulmonary health
- Evidence of pregnancy or current nursing
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298
Actively Recruiting
Research Team
P
Paula Rodriguez Miguelez
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here